-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
CinCor Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2021 to Q3 2022.
- CinCor Pharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was -$1.27M, a 195% decline year-over-year.
- CinCor Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was $8.53M.
- CinCor Pharma, Inc. annual Nonoperating Income (Expense) for 2021 was $7.86M, a 570% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)